We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
-10.84%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$18.9B
AUM Growth
-$4.81B
Cap. Flow
-$1.93B
Cap. Flow %
-10.23%
Top 10 Hldgs %
9.98%
Holding
1,280
New
70
Increased
296
Reduced
563
Closed
80

Top Buys

Rank Stock Value
1
DDS icon
Dillards
DDS
+$60.5M
2
TECH icon
Bio-Techne
TECH
+$31.2M
3
KFY icon
Korn Ferry
KFY
+$30.5M
4
FWRD icon
Forward Air
FWRD
+$25.9M
5
GNTX icon
Gentex
GNTX
+$23.1M

Sector Composition

Rank Sector Weight
1 Industrials 26.86%
2 Technology 17.85%
3 Consumer Discretionary 17.6%
4 Financials 12.03%
5 Healthcare 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPX
951
DELISTED
WPX Energy, Inc.
WPX
$1.17M 0.01%
176,000
RAS
952
DELISTED
RAIT Financial Trust
RAS
$1.14M 0.01%
230,045
-54,500
-19% -$299K
PMC
953
DELISTED
PharMerica Corporation
PMC
$1.14M 0.01%
40,000
PHX
954
DELISTED
PHX Minerals
PHX
$1.14M 0.01%
70,402
+16,794
+31% +$298K
PRSO icon
955
Peraso
PRSO
$7.02M
$1.1M 0.01%
92
NOR
956
DELISTED
NORANDA ALUM HLDG CORP COM NEW
NOR
$1.1M 0.01%
669,035
+126,865
+23% +$431K
ALCO icon
957
Alico
ALCO
$295M
$1.1M 0.01%
27,000
DNB
958
DELISTED
Dun & Bradstreet
DNB
$1.07M 0.01%
10,200
-300
-3% -$34.3K
LOCK
959
DELISTED
LifeLock, Inc.
LOCK
$1.07M 0.01%
+122,000
New +$1.2M
BCRH
960
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$1.06M 0.01%
61,692
-127,408
-67% -$2.14M
DSCI
961
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$1.04M 0.01%
221,507
-170,993
-44% -$1.1M
DSGR icon
962
Distribution Solutions Group
DSGR
$1.61B
$1.03M 0.01%
95,538
ARGO
963
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$1.03M 0.01%
23,099
MCHB
964
Mechanics Bancorp
MCHB
$3.43B
$1.02M 0.01%
44,200
IDTI
965
DELISTED
Integrated Device Technology I
IDTI
$1.01M 0.01%
50,000
-594,000
-92% -$11.6M
OHAI
966
DELISTED
OHA Investment Corporation
OHAI
$976K 0.01%
230,820
NVCN
967
DELISTED
Neovasc Inc.
NVCN
$958K 0.01%
8
+6
+300% +$859K
RPRX
968
DELISTED
Repros Therapeutics Inc.
RPRX
$958K 0.01%
129,000
-62,000
-32% -$474K
LSAK icon
969
Lesaka Technologies
LSAK
$366M
$937K 0.01%
56,000
+19,600
+54% +$372K
FDIQ
970
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$40.6M
$936K 0.01%
+23,000
New +$968K
POWI icon
971
Power Integrations
POWI
$2.7B
$936K 0.01%
44,408
RGLD icon
972
Royal Gold
RGLD
$21.3B
$935K 0.01%
19,900
CIGI icon
973
Colliers International
CIGI
$4.63B
$934K 0.01%
+23,000
New +$985K
POPE
974
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$934K 0.01%
13,900
GES
975
DELISTED
Guess Inc
GES
$929K ﹤0.01%
43,500
+32,300
+288% +$699K

Similar funds

Royce & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Royce & Associates held 1,280 positions worth $18.9B, down 20% from $23.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Royce & Associates withdrew a net $1.93B in Q3 2015, closing 80 positions and reducing 563 holdings. Its most notable exit was FRISCH'S RESTAURANTS INC, an estimated $27.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Dillards worth $54.6M.

  • Royce & Associates's largest Q3 2015 buy was Dillards: 625,355 shares worth $54.6M.
  • Royce & Associates added most to Bio-Techne in Q3 2015, an estimated $31.2M increase.
  • Royce & Associates's biggest Q3 2015 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $93.3M.
  • Royce & Associates fully exited FRISCH'S RESTAURANTS INC in Q3 2015, selling an estimated $27.4M.
  • Royce & Associates's ten largest holdings make up 10% of its $18.9B portfolio in Q3 2015.
  • Royce & Associates opened 70 new positions and closed 80 in Q3 2015.
  • Royce & Associates's portfolio value fell 20% quarter-over-quarter to $18.9B.

Based on Royce & Associates's 13F filing for Q3 2015, filed 12 Nov 2015.